🚀
South China Morning Post3h ago
AI Drug Startup Signs $2.75B Deal With Eli Lilly
Hong Kong-based Insilico Medicine just landed a potential $2.
75 billion partnership with pharmaceutical giant Eli Lilly, marking one of the largest AI drug development deals ever.
The agreement shows how artificial intelligence is transforming medicine from science fiction into life-saving reality.
Want to know more?
1/5